Corteva Inc

Corteva Inc (CTVA) Stock Analysis

$12.880

-0.500 (-3.88%)At close

Loading chart…
High
12.930
Open
12.840
VWAP
12.74
Volume
27.21M
Mkt Cap
37.39B
Low
12.410
Amount
346.71M
EV/EBITDA, TTM
5.03

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.

AI analysis of Corteva Inc (CTVA)

Hold

Corteva Inc (CTVA) is currently priced at $13.24, which is below several analyst price targets, including $17 from KeyBanc and $19 from JPMorgan. However, the stock has a low RSI of 6.83, indicating it is oversold, and a forward P/E ratio of 19.08 suggests potential undervaluation. The main risk is the significant decline in stock performance, with a 20-day change of -84.22% and a 1-year change of -78.87%, which reflects ongoing market skepticism.

Valuation Metrics

The current forward P/E ratio for Corteva Inc (CTVA) is 19.08, compared to its 5-year average forward P/E of 20.35.

Forward P/E

Fair
5Y Average P/E
20.35
Current P/E
19.08
Overvalued
22.42
Undervalued
18.28

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
12.04
Current EV/EBITDA
5.03
Overvalued
14.35
Undervalued
9.73

Forward P/S

Strongly Undervalued
5Y Average P/S
2.37
Current P/S
1.11
Overvalued
2.70
Undervalued
2.05

Alphio AI Price Scenarios for CTVA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%CTVA

$82.20

Scenario price

B

Base

Base · 50%CTVA

$67.79

Scenario price

B

Bear

Bear · 25%CTVA

$54.24

Scenario price

Whales holding CTVA

S

Staley Capital Advisers, Inc.

+ HoldingCTVA

+2.60%

3M Return

C

Clifford Swan Investment Counsel LLC

+ HoldingCTVA

+2.33%

3M Return

Z

ZWJ Investment Counsel Inc

+ HoldingCTVA

+0.84%

3M Return

D

Dearborn Partners L.L.C.

+ HoldingCTVA

+0.39%

3M Return

R

Rokos Capital Management LLP

+ HoldingCTVA

-0.24%

3M Return

A

Aristotle Capital Management, LLC

+ HoldingCTVA

-0.45%

3M Return

Events Timeline

2026-10-15 (ET)

10:30:00

RBC Cuts FMC Q3 EBITDA Guidance to $538M

2026-10-06 (ET)

16:30:00

McKesson and CD&R Agree to Acquire Option Care Health for $32.05 per Share

12:00:00

Major Averages Rise for Second Day Amid Treasury Yield Retreat

10:00:00

Constellation Energy Gains $41.50 to $309.12

09:00:00

Stock Futures Rise as Oil Prices Ease

News

CTVA FAQ — answered by Alphio AI

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products. It operates in the Basic Materials sector.

Corteva Inc (CTVA) is currently priced at $13.24, which is below several analyst price targets, including $17 from KeyBanc and $19 from JPMorgan. However, the stock has a low RSI of 6.83, indicating it is oversold, and a forward P/E ratio of 19.08 suggests potential undervaluation. The main risk is the significant decline in stock performance, with a 20-day change of -84.22% and a 1-year change of -78.87%, which reflects ongoing market skepticism.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading